Viking Therapeutics, Inc. · NASDAQ:VKTX
Viking Therapeutics, Inc. shareholders
As of Jun 30, 2026, 422 institutions reported holding Viking Therapeutics, Inc., 64.9% of its shares. Largest: Vanguard, Fidelity and BlackRock. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Viking Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Vanguard | 10.5M | 9.0% | +96,312 | Aug 13, 2026 |
| Fidelity | 6.34M | 5.4% | +311K | Aug 13, 2026 |
| BlackRock | 6.19M | 5.3% | −691K | Aug 7, 2026 |
| State Street | 5.61M | 4.8% | +1.21M | Aug 7, 2026 |
| Two Sigma | 3.95M | 3.4% | −481K | Aug 14, 2026 |
| Morgan Stanley | 3.49M | 3.0% | +472K | Aug 13, 2026 |
| Ameriprise | 2.16M | 1.8% | +477K | Aug 14, 2026 |
| Geode Capital | 2.1M | 1.8% | +15,914 | Aug 12, 2026 |
| American Century | 1.82M | 1.6% | −263K | Aug 12, 2026 |
| D. E. Shaw & Co., Inc. | 1.61M | 1.4% | −70,719 | Aug 14, 2026 |